Introduction
A tissue, whether normal or abnormal, can grow by increasing the number of cells or by increasing the size of the cells. Although both mechanisms may be operative, an increase in cell number is (with very few exceptions) by far the most important component in either normal or abnormal growth (Baserga, 1985) . The cell number of a given cell population is determined by the balance between cell division and cell death. The importance of cell death in regulating cell number has been known for a long time (reviewed in Baserga, 1985) , but it has become more popular recently with the widespread interest of researchers in apoptosis. Apoptosis and necrosis are the violent ways for cells to die. But cells in vivo and in vitro can also die in a quieter, less dramatic way. In many cases, cells stop dividing and undergo dierentiation, a process that develops over days or even weeks, before eventually leading to cell death. In fact, in physiological states, death by terminal dierentiation is the major way by which the adult animal maintains the balance between cell reproduction and cell loss. If the growth of a cell population depends on a balance between cell division and cell death, the next question is what regulates this balance. Among the many factors that regulate cell reproduction and cell death (genetics, epigenetics, environmental, mechanical) , growth factors (either stimulatory or inhibitory) are certainly important. Growth factors can regulate the size of any cell population in many ways. They can be mitogenic, they can increase cell size, they can induce dierentiation and, ®nally, they can also regulate cell death by protecting cells from apoptosis.
The insulin-like growth factor 1 receptor An ideal paradigm for studying how growth factors regulate the delicate balance between cell reproduction and cell death is oered by the insulin-like growth factor I receptor (IGF-IR), activated by its ligands. The IGF-IR is known to be mitogenic in vivo and in vitro, it promotes growth in size of the cell, it sends a powerful anti-apoptotic signal, can induce dierentiation in some cell types and plays a major role in the transformation of cells. Thus, the IGF-IR acts in at least ®ve dierent ways in controlling the size of a cell population . This is not the place to review the anatomy of the IGF axis, but some essential information is necessary. The IGF axis consists of the IGF-IR, three ligands and several IGF binding proteins, which modulate IGF action, but also have a life of their own. There is also an IGF-II receptor, but it serves largely as a sink for the regulation of IGF-II levels, and its function is not relevant to the present discussion. The fully functional IGF-IR is a dimer that is activated by at least three dierent ligands, IGF-I, IGF-II and insulin (at high concentrations). It consists (like the insulin receptor, IR) of an extra-cellular ligand binding subunit, the a subunit, and of a transmembrane b subunit, which is linked to the a subunit by disul®de bonds. It has 70% homology to the IR, with which it shares some of the signaling pathways. The Cterminus of the IGF-IR (roughly the last 100 aminoacids) has the least homology to the IR, is dispensable for mitogenesis and protection from apoptosis, but is required for dierentiation and the transformation of cells in vitro and in vivo. Ligand binding causes autophosphorylation of the receptor on tyrosine residues. The mitogenicity of the IGF-IR, activated by its ligands has been known for a long time (Scher et al., 1979) , it extends to most (but not all) cell types, and has been extensively documented. The antiapoptotic activity of the IGF-IR was discovered more recently, but it is also well documented and has been discussed in more than one review. The reader who wishes to know more about the anatomy of the IGF axis and to explore further the mitogenic and antiapoptotic functions of the IGF-IR can consult the reviews by Baserga et al. (1997 Baserga et al. ( , 1999 , Blakesley et al. (1999) and Grimberg and Cohen (2000) . The last review has the advantages of including the IGF binding proteins, and of being concise while providing many references. In this review, we shall focus on the lesser studied characteristics of the IGF-IR: the ability (under certain conditions) to induce dierentiation, the ability to regulate cell size, its role in the malignant transformation of cells, and its role in cell adhesion and cell motility.
The IGF-IR in differentiation
In most cell types in cultures (mouse embryo ®broblasts like 3T3 cells, human diploid ®broblasts, some epithelial cells, etc.), the IGF-IR sends an unambiguous mitogenic signal. Indeed, IGF-I was originally classi®ed as a stimulatory growth factor necessary for the transition of cells from G/1 to S phase (Scher et al., 1979) . In other cell types, IGF-I and IGF-II can stimulate either proliferation or dierentiation, or both. For instance, under certain conditions, myoblasts, osteoblasts, adipocytes, oligodendrocytes, neurons and hemopoietic cells can be induced to dierentiate by IGF-I or IGF-II (reviewed by Petley et al., 1999) . The role of the IGF system in dierentiation has been studied in detail in myoblasts. Myoblasts in cultures are undierentiated cells, which can grow inde®nitely in serum, but dierentiate into myocytes, if the serum is removed or decreased. If, after serum removal, the cells are incubated with either IGF-I or IGF-II, they are stimulated to proliferate, but the stimulation is short-lived and is followed by dierentiation (Navarro et al., 1997) . If myoblasts are stably transfected to constitutively express IGF-II, they proliferate normally in serum, but undergo enhanced dierentiation when they are placed in decreased serum conditions (Stewart et al., 1996) . Dierentiation of hemopoietic cells occurs only if the cells can undergo one or two rounds of replication (Valtieri et al., 1987; Ward et al., 1999; Brown et al., 1999) . For instance, the Granulocytic-Colony Stimulating Factor (G-CSF) sends at the same time a proliferative and a dierentiating signal (Valtieri et al., 1987) . The cells grow in number, but also dierentiate, and, apparently, one depends on the other. A similar observation in hemopoietic cells has also been made for IGF-Imediated dierentiation (Liu et al. 1998a ). Terminal dierentiation is usually followed by cell death.
The response of hemopoietic cells to IGF-I can be studied advantageously in 32D cells. 32D cells are murine hemopoietic cells of the myeloid lineage, which undergo apoptosis within 24 h after withdrawal of Interleukin-3 (IL-3) (Valtieri et al., 1987; Zhou-Li et al., 1997) . An important characteristic of 32D cells is that they have very low levels of IGF-IR and do not express IRS-1 or IRS-2, that are among the major substrates of the IGF-IR and the IR (White, 1998) . When 32D cells over-express (even modestly) the IGF-IR, they survive in the absence of IL-3 and, with the addition of IGF-I, they actually grow for about 48 h Soon et al., 1999) . Then, the cells begin to dierentiate along the granulocytic pathway, and eventually decrease in number , as one expects from terminally dierentiated cells.
The fact that 32D cells do not express IRS-1 suggested an explanation for the ability of the IGF-IR, usually mitogenic, to induce dierentiation of 32D IGF-IR cells. If 32D IGF-IR cells are stably transfected with the IRS-1 cDNA, to generate 32D IGF-IR/IRS1 cells, the cells no longer dierentiate , grow inde®nitely in the absence of IL-3 and actually form tumors in animals . Conversely, if 32D cells are transfected with a plasmid expressing Shc proteins (another major substrate of the insulin and IGF-I receptors), they rapidly dierentiate. To complete the story, a dominant negative mutant of Shc induces partial dierentiation even of 32D IGF-IR/IRS1 cells . Thus, at least in the case of 32D cells and the IGF-IR, the`cell context' is simple: when IRS-1 is the predominant substrate, the cells are programmed for proliferation. If Shc proteins predominate, the cells have a tendency to dierentiate. In other words, the cell context is the availability of individual substrates of the IGF-IR.
32D cells over-expressing both the IGF-IR and IRS-1, not only no longer dierentiate, but they actually undergo malignant transformation. As mentioned above, they can be passaged inde®nitely in the absence of IL-3 and form tumors in both syngeneic and nude mice . 32D cells expressing only the IGF-IR cannot be passaged without IL-3, nor do they form tumors in animals, as one would expect from cells undergoing dierentiation. 32D cells that overexpress only IRS-1 do not even survive for 24 h in the absence of IL-3 (Zamorano et al., 1996; Zhou-Li et al., 1997; Valentinis et al., 1999) . Thus, IRS-1 or the IGF-IR, singly, cannot transform 32D cells, or even induce their prolonged survival. In combination, they cause malignant transformation of 32D cells. The presence of a single transducing molecule makes the dierence between malignant transformation and terminal dierentiation.
Another intriguing aspect of this system (32D/IGF-IR cells versus 32D/IGF-IR/IRS-1 cells) is that 32D IGF-IR cells are stimulated to proliferate for the ®rst 48 h, before they dierentiate. This is very important, because, in terms of cell proliferation, one cannot detect any dierence between 32D IGF-IR and 32D IGF-IR/IRS-1 cells, for the ®rst 2 days. It seems that a dierentiating agent, as, for instance IGF-I or G-CSF, can induce simultaneously the proliferative and the dierentiating programs, with the latter eventually prevailing. An attractive hypothesis is that the main function of IRS-1 in our model is to inhibit the activation of the dierentiation program, while leaving intact the proliferation program, resulting in continuous cell proliferation. This hypothesis can be tested by looking at markers of dierentiation in hemopoietic cells, markers that can be detected very early, while the cells are still proliferating (Borregard and Cowland, 1998) . We have taken as a marker of dierentiation the myeloperoxidase (MPO) mRNA, and the Id proteins mRNA. MPO mRNA is known to increase in dierentiating cells, with the protein becoming detectable in about 48 h. In 32D IGF-R cells, the MPO mRNA is detectable even at 24 h after removal of IL-3 and supplementation with IGF-I, and increases further at later times. Instead, in 32D IGF-IR/IRS1 cells, MPO mRNA does not increase under the same conditions, remaining at very low levels . Similar results were obtained with Id proteins mRNAs. The Id proteins are helix-loop-helix (HLH) proteins that act as dominant inhibitors of basic HLH transcription factors, by forming transcriptionally inactive heterodimers (Norton et al., 1998) . Id proteins have been reported to inhibit the dierentiation of several types of cells, including B lymphocytes (Sun, 1994) and myeloid cells (Kreider et al. 1992) . It has been argued that their down-regulation is necessary for cells to dierentiate (although exceptions have been reported). In experiments in our laboratory, (Prisco et al. in preparation) , Id proteins mRNAs are markedly decreased in 32D IGF-IR cells, but not in transformed 32D cells. Thus, on the basis of our results, it is likely that the IGF-IR does indeed activate both a proliferative and a dierentiation program. IRS-1 would simply extinguish the dierentiation program, while leaving intact the proliferative program.
Regulation of cell size by the IGF-IR
An eect of IGF-IR signaling on cell size was suggested by the experiments of Surmacz et al., (1987) , who showed that IGF-I could activate the ribosomal DNA promoter. The synthesis of ribosomal RNA implies a larger number of ribosomes, hence more protein synthesis, and an enlargement of cells (Baserga, 1985) . A role of IGF-IR signaling in determining cell size was further supported by the ®nding that p70 S6K knock-out mice are somewhat smaller than their wild type littermates (Shima et al., 1998) . Similarly, mice with a targeted disruption of the IRS-1 genes are smaller than their wild type littermates. IRS-1 is one of the major substrates of the IGF-IR and p70 S6K is a downstream eector of IRS-1 (Myers et al., 1994) . But the importance of IRS-1 and p70 S6K in cell size regulation was rigorously demonstrated by the recent observation that homologues of either IRS-1 (Bohni et al., 1999) or the S6 kinase (Montagne et al., 1999) regulate cell size in Drosophila. The importance of the IRS-1/PI3-kinase/Akt, p70 S6K pathway in the regulation of cell size has received its latest con®rmation by the ®nding that Akt itself can regulate cell size in Drosophila (Verdu et al., 1999) .
We have con®rmed these ®ndings in murine hemopoietic 32D cells , which have already been discussed above. We have determined cell size by forward scatter in 32D IGF-IR cells and in 32D IGF-IR/IRS1 cells, the only dierence between the two cell lines being the presence or absence of IRS-1. Cell size is increased in 32D IGF-IR/IRS-1 cells, when compared to 32D IGF-IR cells. Table 1 gives the mean values obtained by FACS analysis and includes some of the necessary controls. The most important control is the comparison of the G 1 and G 2 sub-populations of the same cell line. Since G 2 cells are twice as large as G 1 cells, the dierence in the mean forward scatter indicates a doubling in size. The dierence in the means between 32D IGF-IR cells and 32D IGF-IR/IRS1 cells is essentially the same as the dierence between G 1 and G 2 cells, clearly demonstrating that the presence of IRS-1 markedly increases cell size.
Interestingly, the size of 32D IGF-IR/IRS1 cells decreases when the cells are treated with rapamycin. Rapamycin inhibits p70 S6K and causes the dierentiation of 32D IGF-IR/IRS1 cells. The increase in the mean of the forward scatter is small but highly reproducible, and, for a proper assessment, one should compare these data with Figure 2 of Bohni et al. (1999) . In that ®gure, Bohni et al. (1999) used, like us, FACS analysis to estimate the eect of chico (the Drosophila homologues of IRS-1) on cell size in Drosophila. Their dierence was 10 ± 14%, the same dierence we have noticed in our cells.
Since cell size correlates with ribosomal RNA amounts, if dierentiated cells are smaller than transformed cells, they should contain less ribosomal RNA. This prediction was con®rmed by Comai et al. (2000) , who found that TPA-induced dierentiation of human promyelocytic leukemic cells results in inhibition of RNA polymerase I transcription. This inhibition is apparently due to the nucleolar translocation of the retinoblastoma (Rb) gene product (Rogalsky et al., 1993; Voit et al., 1997) The IGF-IR and the transformation of cells
The ®rst inkling that the IGF-R plays a crucial role in malignant transformation was provided by Sell et al. (1993) , who found that R-cells could not be transformed by the SV40 large T antigen. R-cells are 3T3 cells originating from mouse embryos with a targeted disruption of the IGF-IR genes Liu et al., 1993) . Mouse embryo ®broblasts (MEF), including 3T3 cells from several strains of mice, have a tendency to transform spontaneously in cultures (reduced growth factor requirements, foci formation in monolayer cultures and formation of colonies in soft agar), and the SV40 T antigen is, by itself, a strong transforming agent in MEF. The failure of R-cells to become transformed by the SV40 T antigen indicated a role of the IGF-IR in the transformation of cells in culture. This ®nding has since been con®rmed with dierent viral and cellular oncogenes and in dierent laboratories. The list of agents that fail to transform Rcells include the SV40 T antigen and/or an activated Ha-ras oncogene (Sell et al., 1993 , the bovine papilloma virus E5 protein , the human papilloma virus E7 protein (Steller et al., 1996) , the Ewing sarcoma fusion protein (Toretsky et al., 1997) , an activated c-src , an over-expressed IRS-1 (D'Ambrosio et al., 1995) and over-expressed growth factor receptors, such as the EGF , PDGF (DeAngelis et al., 1995) and insulin (Miura et al., 1995) receptors. All these agents readily transform MEF with endogenous IGF-IR. Accordingly, re-introduction of an IGF-IR into R-cells promptly renders these cells susceptible to transformation. The only oncogene, so far, known to transform R-cells is v-src .
An over-expressed IGF-IR is itself transforming (Kaleko et al., 1990 , Pietrzkowski et al., 1992 , but almost anything that is over-expressed in MEF is transforming, including glycolytic enzymes. In the case The IGF receptor R Baserga of R-cells, our interpretation is that there is a signal originating from the IGF-IR that facilitates and is quasi-necessary for transformation by the usual agents (physical, chemical, genetic etc.) . For instance, one could visualize a scenario in which the IGF-IR downregulates the expression of a tumor suppressor gene. In the absence of the IGF-IR, this tumor suppressor gene would be strongly expressed, resulting in the suppression of the transformed phenotype. Interestingly, an IGF-IR devoid of its C-terminus (truncated at either residue 1229 or 1245) is still mitogenic, but no longer transforming in R-cells, even when grossly overexpressed Hongo et al., 1996) . These truncated receptors are not only mitogenic but they also protect MEF and hemopoietic cells from apoptosis (O'Connor et al., 1997 . They are functional receptors that have lost the ability to transform R-cells. Since R-cells have high levels of IRS-1, (and the truncated receptors fully activate it), this observation suggests that a signal from the Cterminus is missing. The missing signal could be either an oncoprotein, or a signal that down-regulates the levels of a tumor suppressor gene. There is indirect evidence that the latter interpretation may be the correct one. Wieland and co-workers (Wieland et al., 1999) have reported recently a gene, which is deleted in human lung cancer (as well as in other human tumors). They called the deleted gene, DICE-1 (deleted in lung cancer), and established it as a solid tumor suppressor gene. A homologue of DICE-1 (DBI-1) is expressed in R-cells with the truncated IGF-IR (non-transforming), but not in R-cells with the wild type receptor (Ho et al., 1998) . One can speculate that the IGF-IR, through its C-terminus, sends a signal that inhibits the expression of DICE-1 (or another tumor suppressor gene). Removal of the C-terminus (or of the whole receptor) would allow DICE-1/DBI-1 to be expressed and exert its anti-transformation eect. Note that the level of expression of the IGF-IR needs not to be high. Even low levels of expression are sucient to send the permissive signal that allows oncogenes to transform mammalian cells. There is another connection between the IGF-IR and cell transformation, which is the other way around. Certain tumor suppressor genes repress transcription from the IGF-IR promoter, causing its down-regulation. Prominent among these tumor suppressor genes that inhibit transcription from the IGF-IR promoter are the p53 gene product and the product of the WT1 gene (reviewed in Werner, 1999) . Tumor suppressor genes are often pro-apoptotic agents, and it is therefore not surprising that they may down-regulate the expression of the IGF-IR, a powerful antiapoptotic agent. In the case of 32D cells, p53 cannot induce apoptosis unless it can ®rst down-regulate IGF-IR levels. 32D cells that carry an IGF-IR plasmid under the control of a viral promoter that cannot be inhibited by p53, do not undergo p53-mediated apoptosis .
Quid est veritas?
Some metaphysical considerations are in order at this point. In all the experiments mentioned above, the investigators (including us) have made liberal use of over-expressed transgenes, knock-outs and peculiar cell lines with unusual characteristics. Yet, a puzzling criticism that is often heard is whether using cell lines that do not express or over-express certain genes (for instance, the IGF-IR or IRS-1) has any physiological signi®cance. Suggestions have been made that these cell lines are`arti®cial'. I must confess that I cannot follow this logic. First of all, from the moment cells are placed in culture (even primary cultures), everything is arti®cial. Smooth muscle cells that never express PDGF receptors in animals, suddenly put out these receptors, avidly looking for growth factors. Cells that were in suspension in the animal suddenly remember that they can make integrins and attach to the substratum, and so on. How can one therefore say that a cell line is more arti®cial than another cell line? Where does one draw the`arti®ciality' line? Furthermore, dierential gene expression is the basis of dierentiation itself. Certain genes are expressed in certain cell types and not in others; other genes are expressed in another cell type, and repressed in another. Dierential gene expression is what gives us epithelial cells, hemopoietic cells, neurons, ®broblasts, mammary glands, hepatocytes, and so on. Are neuronal cells arti®cial because they make neurites that other cells do not make? Indeed, several cell lines are now known that do not express IRS-1, and most of them are prone to dierentiation by various agents (Kim et al., 1998) . Perhaps, these cell lines are trying to tell us something.
In addition, in almost any recent issue of a molecular or cell biology journal, it would be dicult to ®nd a paper that does not use either a transgene, or a knock-out or a dominant negative mutant, in order to understand the function of a given gene product. If one makes a knock-out mouse to study the function of IRS-1 (as it has been done), what is wrong in using a cell line (like 32D cells) that has done, so to speak, its own knock-out? I think we have to accept the fact that no cell line, or no two cell lines or combination of cell lines, ever tell the whole truth, and this applies also to primary cultures. Each cell line tells a part of the truth, and then it is left to the scienti®c community to piece together the various bits of truth to come to a comprehensive picture.
As an illustration of what I am trying to say, let us take the question: does the IGF-IR play any role in neuronal dierentiation? There is ample evidence that the IGF-IR is involved in neuronal dierentiation (and survival) . Interference with the IGF system causes alterations in neuronal dierentiation and/or survival (Leventhal et al., 1999) . This does not mean that the IGF-IR is either the sole or even the most important growth factor receptor in neuronal dierentiation. Indeed, it is very likely that other growth factor receptors are more important than the IGF-IR in this context. But the point is that the IGF-IR does play a role in neuronal dierentiation, and one is justi®ed to investigate the mechanism by which the IGF-IR modulates cell dierentiation. In the year 2000, deleting a gene or inhibiting it with a dominant negative mutant or exaggerate its eect by over-expressing it are all legitimate and widely used methodologies to study the function of a gene product. One can study one component of a system, and let the scienti®c community piece together the various components of the system. The problem, in my opinion, is not the use of Oncogene The IGF receptor R Baserga one or two or three dierent cell lines. The problem is that sometimes researchers extrapolate their results in a cell line to a universe of cell types. It is the old tribal game of`my growth factor is better than yours, my receptor is better than yours, my cell line is better than yours', etc., etc. The truth of the matter is that, in any laboratory, the results obtained are valid only for the cell line and under the speci®c conditions that have been used. But the partial truth thus uncovered is part of a larger truth in intact animals. I would oend the intelligence of the reader, if I were to belabor this point, the point that each of us takes advantage of artifacts to study a mechanism. But, if one wishes to bring up examples, one has only to think that the proliferation of cells (in vivo or in vitro) depends (among other things) on growth factors and their receptors. Yet, all the world of cyclins and cyclindependent kinases (the machinery of cell proliferation) was discovered in yeast, and yeast does not even have tyrosine kinase receptors (as Tony Hunter put it elegantly:`Tyrosine kinase receptors are an invention of metazoans'). Add to these considerations the existence of redundancies in signal transduction and one obtains a picture that should teach us not aggression but humility.
The aim of this review, for instance, is not to show that the IGF-IR is the monarch of receptors; it is to examine how the IGF-IR, one of the components of cell physiology, signals its function.
Targeting of the IGF-IR induces apoptosis of tumor cells
If the IGF-IR is quasi-obligatory for cell transformation, it follows as a corollary that down-regulation of the IGF-IR in malignant cells ought to reverse the transformed phenotype. In fact, this prediction turned out to be conservative. Down-regulation of the IGF-IR function, either by antisense strategies (Resnico et al., 1994a,b; 1995a,b; Shapiro et al., 1994 , Lee et al., 1996 Burfeind et al., 1996; Liu et al., 1998b) , or by dominant negative mutants (Prager et al., 1994; Reiss et al., 1998) or by triple-helix formation (Rininsland et al., 1997) causes massive apoptosis of tumor cells in vitro and in vivo. As a consequence of the extensive apoptosis of tumor cells, down-regulation of IGF-IR function results in inhibition of tumorigenesis (Arteaga, 1992; Kalebic et al., 1994; Trojan et al., 1992; Resnico et al., 1994a,b; Shapiro et al., 1994; and metastases (Long et al., 1995; Burfeind et al., 1996; Dunn et al., 1998 ). An interesting feature of IGF-IR targeting is that it has only a modest eect on cells in monolayer cultures. It seems that the IGF-IR is not an absolute requirement for normal growth, as con®rmed also by genetic experiments (Ludwig et al., 1996) . It is, however, a strict requirement for anchorage-independent growth . Human prostatic tumor cells stably expressing a dominant negative mutant of the IGF-IR are not inhibited when growing in monolayer, but fail to form colonies in soft agar or tumors in mice . This dierential eect on normal growth (cells in monolayer cultures) and abnormal growth (anchorageindependent growth) indicates that targeting of the IGF-IR is a promising candidate for use in cancer chemotherapy.
Structural basis for receptor diversity Fambrough et al. (1999) have recently reported that mutations at dierent sites of the PDGFb receptor, that inactivate speci®c signaling pathways, result in the activation of the same Immediate Early Genes (IEG), whose expression is required for cell cycle progression. Their ®nding indicates that there is a network of signaling pathways, full of redundancy, and leading to the activation of the same genes (Pawson and Saxton 1999). In the case of the PDGFb receptor, dierent domains can substitute for others in delivering the same mitogenic signal. We have been making similar observations with the IGF-IR. In the past few years, we have examined dierent functions of the IGF-IR, including mitogenicity, protection from apoptosis, ability to transform cells, and ability to induce dierentiation Valentinis et al., 1999 , and reviewed in Baserga et al., 1997 , 1999 . The results obtained with several mutant receptors and in dierent cell lines have given us a map of the b subunit domains of the IGF-IR and their functions (Figure 1 ). To begin with (and not shown in Figure 1 ), a mutation at lysine 1003 (the ATP-binding site) results in a receptor that has completely lost its functions. Such a mutant receptor is a disabled receptor and tells us only that autophosphorylation of the receptor is a necessary component for its function (at least for the functions examined above). A triple mutation in the tyrosine kinase domain (Y1131, Y1135 and Y1136), results in a receptor that is also seriously defective and fails to transmit a mitogenic signal (Gronborg et al., 1993; Li et al., 1994) . We can therefore say that the tyrosine kinase domain of the IGF-IR is necessary for its mitogenic signal. It is necessary, but it is also sucient (with lysine 1003), as other mutations at various residues have no eect on the mitogenicity of the receptor (Figure 1 ). Tyrosine 950 and the C-terminus of the receptor are required for dierentiation Morrione et al., 2000) , although they are dispensable for mitogenicity. In the case of dierentiation, however, the immediate substrates of the IGF-IR also play a very important role, as Shc proteins favor dierentiation, while IRS-1 inhibits dierentiation . For cell survival, the IGF-IR uses three dierent pathways originating from dierent domains . The ®rst domain is the tyrosine kinase domain, acting through the IRS-1/Akt/p70 pathway. A second domain is based on activation of Shc, in which Y950 plays a preponderant role, which leads to the activation of MAPK (White, 1998) . Finally, a third domain resides in a serine quartet at 1280 ± 1283, which binds 14.3.3 (Craparo et al., 1997; Furlanetto et al., 1997) and activates Raf, promoting its mitochondrial translocation. Interestingly, for survival, it is sucient that any two of these three pathways be operative to exert protection from apoptosis. Regulation of cell size, like mitogenicity, requires the tyrosine kinase domain, understandably so, as cell size increase is a necessary pre-requisite for mitosis (reviewed in Baserga 1985) . Cell size, in turn, depends on the IRS-1 pathway. For transformation (colony formation in soft agar), nothing short of a full wild type receptor is sucient. Any of the mutations listed in Figure 1 (as well as others) will abrogate transforming activity. This is not to say that there are no silent mutations. The mutations diagrammed in Figure 1 are those that are known to have a function and/or to bind to speci®c substrates. At least in our hands, for example, mutation at Y1316 has no eect whatsoever on the functions of the receptor listed above. The transforming domain of the C-terminus is located between residues 1245 and 1310. In this region, at least three domains are involved, the tyrosine residue at 1251, the serine residues at 1280 ± 1283, and, more weakly, the residues at 1293 ± 1294. More details and the appropriate references on the domains of the IGF-IR can be found in the review by Baserga et al. (1999) and in the papers by Valentinis et al. (1999) and Peruzzi et al. (1999) . Omitted from this brief survey is another function of the IGF-IR: on cell adhesion and cell motility, that will be discussed below.
The IGF axis and the cytoskeleton
Up to this point, we have emphasized the contradictions of the IGF-IR, like transformation versus dierentiation. It is now time to look at the contradictions of its signaling pathways, in particular the contradictions of its major substrates, like IRS-1 and the Shc proteins. We have mentioned already that IRS-1 sends a strong mitogenic signal, whereas Shc seems to send a dierentiation signal. But Shc proteins have been considered for a long time as transducing a mitogenic signal, from both the insulin and the IGF-I receptors (Pronk et al., 1993) . Another contradiction has also to do with IRS-1 and is based on a puzzling ®nding. Certain human prostatic cancer cells express low levels or do not express at all IRS-1 . At ®rst sight, that seems to be incongruous. Cancer cells have a tendency to use every possible mean to gain a growth advantage, and the extinction of IRS-1 expression is not advantageous for growth. But here too, there is an explanation, which is based on some data already established in the literature. We know that IGF-I increases both cell adhesion and motility Dunn et al., 1998; Zheng and Clemmon, 1998) . We also know that both the IGF-IR and IRS-1 interact with integrins (Guilherme and Czech, 1998), especially aVb3 (Vuori and Ruoslahti, 1994; Jones et al., 1996; Brooks et al., 1997) . IRS-1 is activated, when cells are plated on appropriate substrates Zheng and Clemmons, 1998; Clemmons et al., 1999) , which brings up the possibility of an interaction with FAK (Valentinis et al., 1998) . Indeed, IRS-1 has been reported to be a signaling molecule for pp125 FAK (Lebrun et al., 1998) . Furthermore, IRS-1 has a Grb2 binding site, and Grb2 interacts with integrins (Shakibaei et al., 1999) and integrins with FAK (Renshaw et al., 1999) .
As mentioned above, some human prostatic cancer cells, like LNCaP cells, do not express IRS-1 . LNCaP cells originated from a metastatic tumor, and have a frame-shift mutation of PTEN, a tumor suppressor gene (also called MMAC1 or TEP1) identi®ed on human chromosome 10q23 Steck et al., 1997) . PTEN is a phosphatase (Furnari et al., 1997) that regulates the activity of PI3K (Wu et al., 1998; Davies et al., 1999; Tamura et al., 1999) and can block cells in the G/1 phase of the cell cycle (Furnari et al., 1998; Li and Sun, 1998) . IRS-1 is a strong activator of PI3-kinase (Myers et al., 1994) , which, as already mentioned, is inhibited by PTEN. Ectopic expression of IRS-1 in LNCaP cells increases cell attachment to ®bronectin, laminin and collagen 1 . However, contrary to expectations, IRS-1 expression in these cells markedly reduces cell motility, and this eect is IGF-Iindependent . These eects of IRS-1 have been interpreted by Reiss et al. (2000) as a modality by which prostatic cancer cells could favor their metastatic spread without compromising their ability to grow. By simply extinguishing the expression of IRS-1, the cancer cells would decrease their attachment to substrata and increase motility, thus favoring invasion and metastasis. The loss of the mitogenic stimulus of IRS-1 (White, 1998; Peruzzi et al., 1999) would be compensated by the PTEN mutation, which restores the activity of the PI3-kinase pathway. Indeed, Akt, a downstream target of PI-3 kinase (reviewed in Chan et al., 1999) , is constitutively activated in the parental LNCaP cells (Carson et al., 1998; Davies et al., 1999; Tamura et al., 1999; Reiss et al., 2000) . If this interpretation is correct, then IRS-1 has also its contradictions. It is mitogenic, but, by increasing cell adhesion and decreasing cell motility, could also reduce metastatic spread. There is a corollary to this interpretation. In the absence of IRS-1, the IGF-IR sends a dierentiation signal . One would therefore expect that LNCaP cells, to avoid dierentiation, would have to down-regulate the levels of IGF-IR. This is exactly what they do, and over-expression of the IGF-IR in these cells actually leads to growth arrest . We would like to propose, for the moment, that this sixth, function of the IGF-IR (cell adhesion and motility) may be (like dierentiation) more dependent on the substrates than on the receptor itself, since the eects of IRS-1 on cell adhesion and cell motility are IGF-I-independent.
Conclusions
The IGF-IR has gained popularity in recent years as a receptor that stimulates the growth of cells and their survival, both of which functions are conducive to increased tumor growth. This interpretation has been con®rmed by the numerous observations that downregulation of the IGF-IR leads to apoptosis of tumor cells and inhibition of tumor growth. It is therefore not surprising that targeting of the IGF-IR is also popular with pharmaceutical and biotechnology companies. In this review, I have tried to show that the IGF-IR and its substrates can also send contradictory signals, signals that can actually lead to growth inhibition or to inhibition of metastatic spread. These contradictions ought to become fertile areas of investigation for both basic and applied research.
